HDBSVR: KLCI may see mild technical rebound

KUALA LUMPUR (March 19): Hwang DBS Vickers Research said the key FBM KLCI may see a mild technical rebound on Monday after tumbling in the final few minutes of trading on Friday for a daily loss of 8.0 points.

“On the chart, the immediate support and resistance levels for the benchmark index are currently seen at 1,555 and 1,580, respectively,” it said.

HDBSVR said among the stocks that could attract added interest include Bumi Armada and MISC after a business weekly report that said the two companies (with their respective partners) are the front runners to bag a FPSO vessel contract to be awarded by an US-based oil & gas entity.

Another stock to watch are EP Manufacturing, in response to its proposed acquisition of an expressway concessionaire for RM1.2 billion.

Also in focus would be CCM Duopharma, which has announced a net dividend per share of 10.9 sen, translating to a net yield of 4.6%.



Get your T+10 interest FREE margin trading account NOW. Attractive brokerage for online trading. Contact Mr Ho at +603-5192 0808 or hoxian@sjsec.com.my for more details.

KUALA LUMPUR (Feb 29): The FBM KLCI rose more than 10 points in late morning trade on Wednesday, the most in recent weeks, with consumer-related count

KUALA LUMPUR (Feb 29): The FBM KLCI rose more than 10 points in late morning trade on Wednesday, the most in recent weeks, with consumer-related counters among the major gainers as sentiment perked up in line with the regional markets.

At 11.16am, the KLCI was up 10.32 points to 1,567.05. Turnover was 672.86 million shares valued at RM634.94 million. Advancing counters beat decliners 382 to 218 while 268 stocks were unchanged.

BAT rose RM1.14 to RM53.44m Dutch Lady 42 sen to RM29.40 and Carlsberg 16 sen to RM10.06.

HLFG rose 42 sen to RM12.24, Aeon 41 sen to RM8.60 and PetGas 32 sen to RM16.88 while PPB and CCM Dbio rose 30 sen each to RM17.30 and RM2.50.

Cypark again came under the radar screen, rising 13 sen to RM2.04.



Get your T+10 interest FREE margin trading account NOW. Attractive brokerage for online trading. Contact Mr Ho at +603-5192 0808 or hoxian@sjsec.com.my for more details.

CCM Duopharma 3Q net profit dips to RM7.52m

KUALA LUMPUR (Nov 21): CCM DUOPHARMA BIOTECH BHD []’s earnings dipped 1.3% to RM7.52 million in the third quarter ended Sept 30 from RM7.62 million a year ago due to slightly higher administration expenses.

In its announcement on Monday, the administration expenses increased to RM3.35 million from RM2.40 million a year ago.

However, its revenue increased 6.7% to RM36.76 million from RM34.46 million while earnings per share 5.42 sen compared with 5.49 sen.

For the nine-month period, its earnings rose 1.6% to RM20.37 million from RM20.05 million while its revenue increased at a stronger pace of 5.9% to RM105.09 million from RM99.24 million.

“The increase in revenue was mainly due to increase sales to government hospitals,” it said.



Get your T+10 interest FREE margin trading account NOW. Attractive brokerage for online trading. Contact Mr Ho at +603-5192 0808 or hoxian@sjsec.com.my for more details.